Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors
- 1 October 2000
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (7) , 885-898
- https://doi.org/10.1016/s0006-2952(00)00405-6
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disordersJournal of Oral Pathology & Medicine, 2007
- Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530Oncogene, 1999
- Activating SRC mutation in a subset of advanced human colon cancersNature Genetics, 1999
- c-Src, Receptor Tyrosine Kinases, and Human CancerAdvances in Cancer Research, 1999
- Overexpression and Activation of the Tyrosine Kinase Src in Human Pancreatic CarcinomaBiochemical and Biophysical Research Communications, 1998
- Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potentialOncogene, 1997
- CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASESAnnual Review of Cell and Developmental Biology, 1997
- c-Src PROTEIN EXPRESSION IS INCREASED IN HUMAN BREAST CANCER. AN IMMUNOHISTOCHEMICAL AND BIOCHEMICAL ANALYSISThe Journal of Pathology, 1996
- DNA Synthesis Induced by Some but Not All Growth Factors Requires Src Family Protein Tyrosine KinasesMolecular and Cellular Biology, 1995
- Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.Journal of Clinical Investigation, 1993